Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 216.58 USD 0.95% Market Closed
Market Cap: 35.1B USD
Have any thoughts about
Veeva Systems Inc?
Write Note

Net Margin
Veeva Systems Inc

23.9%
Current
23%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.9%
=
Net Income
615.3m
/
Revenue
2.6B

Net Margin Across Competitors

Country US
Market Cap 35B USD
Net Margin
24%
Country US
Market Cap 31.3B USD
Net Margin
10%
Country AU
Market Cap 23.2B AUD
Net Margin
50%
Country US
Market Cap 9B USD
Net Margin
34%
Country JP
Market Cap 967.6B JPY
Net Margin
16%
Country US
Market Cap 5.7B USD
Net Margin
4%
Country US
Market Cap 5.4B USD
Net Margin
-6%
Country SE
Market Cap 53.1B SEK
Net Margin
25%
Country US
Market Cap 2.4B EUR
Net Margin
-4%
Country CN
Market Cap 16.4B CNY
Net Margin
11%
Country US
Market Cap 2.1B USD
Net Margin
-2%
No Stocks Found

Veeva Systems Inc
Glance View

Market Cap
35B USD
Industry
Health Care

Veeva Systems Inc. is a cloud-based software company that specializes in providing innovative solutions for the life sciences industry. Founded in 2007, Veeva has grown into a leading player, helping pharmaceutical and biotechnology companies manage their critical data and workflow efficiently. With an array of products tailored to various functions such as clinical trials, regulatory compliance, and commercial operations, Veeva’s offerings are designed to streamline processes while ensuring compliance with the stringent regulations that govern the healthcare sector. The company has established a robust reputation and a vast customer base, including many of the world's most prominent drug manufacturers, which highlights its strategic importance in an ever-evolving industry. Investors looking at Veeva Systems should note the company’s impressive growth trajectory, characterized by consistent revenue increases and a strong margin profile. As healthcare increasingly shifts towards digital solutions, Veeva stands at the forefront of this transformation, capturing the growing demand for cloud-based applications. Moreover, Veeva’s commitment to innovation and its customer-centric approach position it well to capitalize on future opportunities within life sciences, particularly as the industry seeks to enhance efficiency and reduce costs. With a strong balance sheet and a business model that emphasizes recurring revenue through subscription services, Veeva Systems presents a compelling investment proposition for those interested in the intersection of technology and healthcare.

VEEV Intrinsic Value
121.68 USD
Overvaluation 44%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
23.9%
=
Net Income
615.3m
/
Revenue
2.6B
What is the Net Margin of Veeva Systems Inc?

Based on Veeva Systems Inc's most recent financial statements, the company has Net Margin of 23.9%.